Review
[HIV may be cured]
[Article in
Danish]
Affiliations
- PMID: 25922162
Item in Clipboard
Review
[HIV may be cured]
[Article in
Danish]
Ugeskr Laeger.
.
Free article
Abstract
The symposium IAS Towards an HIV Cure was held in Melbourne, Australia, in July 2014. There are several challenges regarding an HIV cure, among these the reservoir of latently infected CD4+ T cells which are hidden from the immune system. A new promising approach towards an HIV cure is the "shock and kill" strategy. Here, the latently infected cells are shocked to express HIV on the surface, and afterwards the shocked cells can be eradicated by apoptosis or destruction by the immune system. In this paper the most important results from the symposium are presented.
Similar articles
-
In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.Retrovirology. 2016 May 21;13(1):36. doi: 10.1186/s12977-016-0268-7. Retrovirology. 2016. PMID: 27206407 Free PMC article.
-
HDAC inhibitors in HIV.Immunol Cell Biol. 2012 Jan;90(1):47-54. doi: 10.1038/icb.2011.95. Epub 2011 Nov 15. Immunol Cell Biol. 2012. PMID: 22083528 Review.
-
HIV/AIDS. Report of novel treatment aimed at latent HIV raises the 'c word'.Science. 2005 Aug 12;309(5737):999-1000. doi: 10.1126/science.309.5737.999a. Science. 2005. PMID: 16099956 No abstract available.
-
Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.PLoS Pathog. 2014 Nov 13;10(10):e1004473. doi: 10.1371/journal.ppat.1004473. eCollection 2014 Oct. PLoS Pathog. 2014. PMID: 25393648 Free PMC article. Clinical Trial.
-
The role of latency reversal agents in the cure of HIV: A review of current data.Immunol Lett. 2018 Apr;196:135-139. doi: 10.1016/j.imlet.2018.02.004. Epub 2018 Feb 7. Immunol Lett. 2018. PMID: 29427743 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
